Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $879.4 billion, total revenue of $177.12 billion and a weighted average PE ratio of 45.24.
Market Cap
879.4B
Revenue
177.12B
Profits
19.44B
PE Ratio
45.24
Profit Margin
10.98%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 248.08B | -2.79% | 2,360,721 | 47.35B |
| 2 | DHR | Danaher Corporation | 155.03B | -3.16% | 4,015,646 | 25.61B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 53.28B | -1.95% | 616,302 | 4.66B |
| 4 | A | Agilent Technologies, Inc. | 48.04B | -2.83% | 1,882,470 | 7.37B |
| 5 | WAT | Waters Corporation | 43.29B | -3.51% | 1,353,588 | 5.61B |
| 6 | IQV | IQVIA Holdings Inc. | 40.51B | -1.89% | 1,249,998 | 17.31B |
| 7 | NTRA | Natera, Inc. | 39.64B | -5.70% | 1,385,613 | 2.91B |
| 8 | MTD | Mettler-Toledo International Inc. | 33.15B | -2.27% | 143,694 | 4.20B |
| 9 | LH | Labcorp Holdings Inc. | 29.81B | -0.47% | 890,550 | 14.59B |
| 10 | ILMN | Illumina, Inc. | 29.15B | -3.91% | 1,936,098 | 4.54B |
| 11 | DGX | Quest Diagnostics Incorporated | 28.42B | -0.31% | 1,366,024 | 11.84B |
| 12 | GH | Guardant Health, Inc. | 19.73B | 0.16% | 2,757,523 | 1.28B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.08B | -3.70% | 236,770 | 2.84B |
| 14 | RVTY | Revvity, Inc. | 16.21B | -4.20% | 1,663,176 | 2.94B |
| 15 | CRL | Charles River Laboratories International, Inc. | 15.06B | -4.15% | 1,154,334 | 3.98B |
| 16 | ICLR | ICON Public Limited Company | 13.99B | -1.92% | 735,355 | 8.23B |
| 17 | QGEN | Qiagen N.V. | 10.18B | -0.66% | 2,634,824 | 2.12B |
| 18 | RDNT | RadNet, Inc. | 5.49B | 0.29% | 594,202 | 2.38B |
| 19 | SHC | Sotera Health Company | 4.54B | -1.85% | 1,730,989 | 1.23B |
| 20 | ADPT | Adaptive Biotechnologies Corporation | 4.52B | -0.43% | 2,483,129 | 298.01M |
| 21 | GRAL | GRAIL, Inc. | 4.46B | -5.33% | 757,992 | 166.60M |
| 22 | BLLN | BillionToOne, Inc. | 4.30B | -0.31% | 819,334 | 436.87M |
| 23 | CDNA | CareDx, Inc. | 3.68B | -2.67% | 781,924 | 497.40M |
| 24 | VCYT | Veracyte, Inc. | 2.03B | 0.36% | 2,792,904 | 581.78M |
| 25 | NEO | NeoGenomics, Inc. | 1.92B | -1.79% | 1,177,080 | 787.75M |
| 26 | PSNL | Personalis, Inc. | 1.55B | -3.06% | 3,335,604 | 80.77M |
| 27 | WGS | GeneDx Holdings Corp. | 1.36B | -7.68% | 912,292 | 460.78M |
| 28 | OPK | OPKO Health, Inc. | 1.17B | -2.48% | 3,518,149 | 654.10M |
| 29 | FRNM | Freenome, Inc. | 1.04B | -5.74% | 621,724 | 217.86M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.01B | -1.65% | 309,215 | 377.13M |
| 31 | FLGT | Fulgent Genetics, Inc. | 673.89M | -2.66% | 322,917 | 330.28M |
| 32 | MYGN | Myriad Genetics, Inc. | 523.74M | -1.44% | 1,248,897 | 803.60M |
| 33 | BNR | Burning Rock Biotech Limited | 139.63M | -0.60% | 27,868 | 73.70M |
| 34 | XGN | Exagen Inc. | 92.10M | -5.00% | 508,814 | 72.30M |
| 35 | BDSX | Biodesix, Inc. | 83.83M | -8.92% | 205,355 | 105.21M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 64.47M | 18.67% | 1,201,724 | 1.97M |
| 37 | QUCY | Quantum Cyber N.V. | 44.67M | -7.25% | 303,088 | 1.50M |
| 38 | PRPO | Precipio, Inc. | 31.11M | -6.17% | 35,625 | 27.76M |
| 39 | MDXH | MDxHealth SA | 10.25M | -8.52% | 1,087,112 | 114.01M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 5.36M | -3.38% | 15,540 | - |
| 41 | XWEL | XWELL, Inc. | 3.52M | -5.77% | 24,886 | 28.28M |
| 42 | BIAF | bioAffinity Technologies, Inc. | 3.00M | -10.81% | 71,795 | 5.53M |
| 43 | ADVB | Advanced Biomed Inc. | 2.73M | -5.71% | 16,112 | 127.64K |
| 44 | ISPC | iSpecimen Inc. | 2.64M | -13.58% | 151,338 | 603.74K |